Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/1424
Full metadata record
DC FieldValueLanguage
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP-
dc.contributor.authorCRUZ, Livia Almeida da-
dc.contributor.authorHOFF, Paulo Marcelo Gehm-
dc.contributor.authorFERRARI, Claudio Luiz Seabra-
dc.contributor.authorRIECHELMANN, Rachel Simoes Pimenta-
dc.date.accessioned2013-07-30T17:51:49Z-
dc.date.available2013-07-30T17:51:49Z-
dc.date.issued2012-
dc.identifier.citationCLINICAL COLORECTAL CANCER, v.11, n.1, p.82-84, 2012-
dc.identifier.issn1533-0028-
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/1424-
dc.description.abstractThe association between hand-foot syndrome and fluoropyrimidines is well documented in the medical literature. Its etiology is obscure, with a few pathophysiology hypotheses being postulated. Classic hand-foot syndrome is characterized by dermatologic symmetric findings. This is the first case report of unilateral hand-foot syndrome in a patient with colorectal cancer who received capecitabine. Here we discuss possible causes of hand-foot syndrome, bringing new elements to clarify the mechanisms involved in this intriguing adverse effect.-
dc.language.isoeng-
dc.publisherCIG MEDIA GROUP, LP-
dc.relation.ispartofClinical Colorectal Cancer-
dc.rightsrestrictedAccess-
dc.subjectFluoropyrimidines-
dc.subjectHand-foot syndrome-
dc.subject.othercolorectal-cancer-
dc.subject.otherantineoplastic chemotherapy-
dc.subject.otheroral capecitabine-
dc.subject.otherphase-iii-
dc.subject.othertherapy-
dc.subject.othermanagement-
dc.subject.otherfluorouracil-
dc.subject.othersunitinib-
dc.subject.othersweat-
dc.subject.otherskin-
dc.titleUnilateral Hand-Foot Syndrome: Does It Take Sides? Case Report and Literature Review-
dc.typearticle-
dc.rights.holderCopyright CIG MEDIA GROUP, LP-
dc.identifier.doi10.1016/j.clcc.2011.05.004-
dc.identifier.pmid21764392-
dc.subject.wosOncology-
dc.type.categoryeditorial material-
dc.type.versionpublishedVersion-
hcfmusp.author.externalCRUZ, Livia Almeida da:Univ Sao Paulo, Fac Med, Inst Canc Estado Sao Paulo, Dept Med Oncol, BR-05508 Sao Paulo, Brazil-
hcfmusp.description.beginpage82-
hcfmusp.description.endpage84-
hcfmusp.description.issue1-
hcfmusp.description.volume11-
hcfmusp.origemWOS-
hcfmusp.origem.idWOS:000300546700012-
hcfmusp.origem.id2-s2.0-84861547503-
hcfmusp.publisher.cityDALLAS-
hcfmusp.publisher.countryUSA-
hcfmusp.relation.referenceAbushullaih S, 2002, CANCER INVEST, V20, P3, DOI 10.1081/CNV-120000360-
hcfmusp.relation.referenceBAACK BR, 1991, J AM ACAD DERMATOL, V24, P457, DOI 10.1016/0190-9622(91)70073-B-
hcfmusp.relation.referenceDegen A, 2010, J DTSCH DERMATOL GES, V8, P652, DOI 10.1111/j.1610-0387.2010.07449.x-
hcfmusp.relation.referenceDisel U, 2010, CUTAN OCUL TOXICOL, V29, P140, DOI 10.3109/15569521003699585-
hcfmusp.relation.referenceElasmar SA, 2001, JPN J CLIN ONCOL, V31, P172, DOI 10.1093/jjco/hye032-
hcfmusp.relation.referenceGressett Sarah M, 2006, J Oncol Pharm Pract, V12, P131, DOI 10.1177/1078155206069242-
hcfmusp.relation.referenceHoff PM, 2001, J CLIN ONCOL, V19, P2282-
hcfmusp.relation.referenceHorn TD, 1997, ARCH DERMATOL, V133, P905, DOI 10.1001/archderm.133.7.905-
hcfmusp.relation.referenceJacobi U, 2005, ANN ONCOL, V16, P1210, DOI 10.1093/annonc/mdi204-
hcfmusp.relation.referenceJanusch M, 2006, EUR J DERMATOL, V16, P494, DOI 10.1684/ejd.2006.0041-
hcfmusp.relation.referenceKang YK, 2010, J CLIN ONCOL, V28, P3824, DOI 10.1200/JCO.2010.29.1807-
hcfmusp.relation.referenceLacouture ME, 2008, ANN ONCOL, V19, P1955, DOI 10.1093/annonc/mdn389-
hcfmusp.relation.referenceLacouture ME, 2008, ONCOLOGIST, V13, P1001, DOI 10.1634/theoncologist.2008-0131-
hcfmusp.relation.referenceLassere Yvonne, 2004, Eur J Oncol Nurs, V8 Suppl 1, pS31, DOI 10.1016/j.ejon.2004.06.007-
hcfmusp.relation.referenceMilano G, 2008, BRIT J CLIN PHARMACO, V66, P88, DOI 10.1111/j.1365-2125.2008.03159.x-
hcfmusp.relation.referenceNarasimhan P, 2004, CUTIS, V73, P101-
hcfmusp.relation.referenceO'Shaughnessy J, 2000, P AN M AM SOC CLIN, V19, p104A-
hcfmusp.relation.referenceRosenbaum SE, 2008, SUPPORT CARE CANCER, V16, P557, DOI 10.1007/s00520-008-0409-1-
hcfmusp.relation.referenceSaif MW, 2008, CUTAN OCUL TOXICOL, V27, P311, DOI 10.1080/15569520802355774-
hcfmusp.relation.referenceSaif MW, 2006, CLIN COLORECTAL CANC, V6, P219, DOI 10.3816/CCC.2006.n.039-
hcfmusp.relation.referenceScheithauer W, 2003, ANN ONCOL, V14, P1735, DOI 10.1093/annonc/mdg500-
hcfmusp.relation.referenceWalko CM, 2005, CLIN THER, V27, P23, DOI 10.1016/j.clinthera.2005.01.005-
hcfmusp.relation.referenceYen-Revollo JL, 2008, CLIN CANCER RES, V14, P8, DOI 10.1158/1078-0432.CCR-07-1225-
hcfmusp.relation.referenceZUEHLKE RL, 1974, DERMATOLOGICA, V148, P90-
hcfmusp.relation.reference[Anonymous], 1998, J CLIN ONCOL, V16, P3537-
dc.description.indexMEDLINE-
hcfmusp.lim.ref2012-
hcfmusp.citation.scopus8-
hcfmusp.scopus.lastupdate2022-12-09-
Appears in Collections:

Artigos e Materiais de Revistas Científicas - FM/MDR
Departamento de Radiologia - FM/MDR

Artigos e Materiais de Revistas Científicas - HC/ICESP
Instituto do Câncer do Estado de São Paulo - HC/ICESP

Artigos e Materiais de Revistas Científicas - HC/InRad
Instituto de Radiologia - HC/InRad

Artigos e Materiais de Revistas Científicas - LIM/24
LIM/24 - Laboratório de Oncologia Experimental


Files in This Item:
File Description SizeFormat 
art_HOFF_Unilateral_Hand_Foot_Syndrome_Does_It_Take_Sides_2012.PDF
  Restricted Access
publishedVersion (English)478.92 kBAdobe PDFView/Open Request a copy

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.